Cognitive, Motor, and Emotional Markers of Self-reported Cognitive Concerns
Cognitive, Motor, and Emotional Markers of Self-reported Cognitive Concerns
批准号:
8983423
负责人:
Stephanie Anne Kielb
金额:
$4.36万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2018-08-31
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAmericanAreaBehavioralBiologicalBiological MarkersClinicalClinical TrialsCognitionCognitiveCognitive agingComputersDementiaDepressed moodDetectionDevelopmentEarly DiagnosisElderlyEmotionalEmotionsEpisodic memoryEquilibriumEvaluationFutureGaitGait speedGoalsImpaired cognitionImpairmentIndividualMeasurableMeasuresMental DepressionMethodsMotorNeurobehavioral ManifestationsNeurodegenerative DisordersNeurologicNeuropsychological TestsPaperPatient Self-ReportPerformancePopulations at RiskPrevalencePreventionProcessPropertyPsychometricsPublic HealthReaction TimeResearchRiskSelf EfficacyShort-Term MemorySignal TransductionSocietiesStagingStressSymptomsSyndromeTestingUnited States National Institutes of Healthage groupbasecareercognitive changecognitive performancecomputerizedcostfunctional disabilityin vivoinstrumentmemory processmild cognitive impairmentmillisecondmotor controlneuropathologynovel strategiespre-clinicalprocessing speedprognostic valuepublic health relevancetime interval
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dementia of the Alzheimer's type (DAT) is a terminal and incurable neurodegenerative disorder with a very high cost to society. Research in the early detection of DAT is critical to address a looming public health crisis. The presence of self-reported cognitive concerns (SCCs) in the absence of overt cognitive impairment may represent a preclinical stage in the development of DAT. However, research findings are inconsistent and the neurological and behavioral features associated with SCCs are not fully understood. The goal of the proposed study is to characterize cognitive, motor, and emotional markers of SCCs. These markers will be quantified using subtests from the U.S. NIH Toolbox for the Assessment of Neurological and Behavioral Function (NIHTB), a brief but comprehensive set of computer-based measures. Specific Aim 1 will characterize the cognitive markers of SCCs using the NIHTB Cognition Battery, which has advantageous psychometric properties and may be sensitive to detecting subtle cognitive changes not measurable by standard paper-and- pencil neuropsychological tests. Scores on the NIHTB Cognition Battery will be compared across three cognitive aging groups hypothesized to precede DAT: psychometrically normal cognition without SCCs (SCC-), normal cognition with SCCs (SCC+), and mild cognitive impairment (MCI). Performance is expected to follow a continuum with scores best for SCC- group, next best for the SCC+ group, and worst for the MCI group. Additionally, the SCC+ and SCC- groups will be compared regarding the extent to which each demonstrates a practice effect on a repeated evaluation within a three-week interval of time. Previous research shows that practice effects are reduced in MCI, and therefore the SCC+ group is expected to show less of a practice effect than the SCC- group. Specific Aim 2 will characterize non-cognitive markers of SCCs using the NIHTB Emotion Battery and three subtests of the NIHTB Motor Battery. The SCC+ and SCC- groups will be compared on a wide range of positive and negative emotional constructs as well as on gait stability, balance, and fine motor coordination. Based on previous findings that these motor functions are reduced in MCI, the SCC+ group is expected to show slower gait speed, decreased balance, and poorer fine motor coordination than the SCC- group. On the Emotion Battery, the SCC+ group is expected to show greater perceived stress and rejection as well as less self-efficacy and emotional support than the SCC- group. The proposed study will be the first to use NIHTB measures in the context of aging and dementia. Findings will define neurological and behavioral signatures in a group at-risk for DAT. Results may also inform future strategies in the early detection of DAT, which is consistent with the long-term career goal
to investigate noninvasive methods for early detection widely accessible for use in underserved areas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: